A multicenter clinical study to determine the efficacy of a novel fenugreek seed (Trigonella foenum-graecum) extract (Fenfuro™) in patients with type 2 diabetes

@inproceedings{Verma2016AMC,
  title={A multicenter clinical study to determine the efficacy of a novel fenugreek seed (Trigonella foenum-graecum) extract (Fenfuro™) in patients with type 2 diabetes},
  author={Narsingh Verma and Kauser Usman and Naresh M. Patel and Arvind Jain and Sudhir Dhakre and Anand Swaroop and Manashi Bagchi and Pawan Kumar and Harry G. Preuss and Debasis Bagchi},
  booktitle={Food & nutrition research},
  year={2016}
}
BACKGROUND Trigonella foenum-graecum (fenugreek) seeds are known to exhibit potent antioxidant, hypoglycemic, and nephroprotective activities, as well as serve as excellent membrane stabilizers especially because of their content of novel furostanolic saponins. Our previous studies exhibited the broad spectrum safety and efficacy of Fenfuro, a novel T. foenum-graecum seed extract enriched in furostanolic saponins, in type 2 diabetes (T2D) in rats. DESIGN This multicenter, randomized, placebo… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 2 times over the past 90 days. VIEW TWEETS
4 Extracted Citations
39 Extracted References
Similar Papers

Referenced Papers

Publications referenced by this paper.
Showing 1-10 of 39 references

Hypolipidemic effect of fenugreek: a clinical study

  • M. Prasanna
  • Indian J Pharmacol
  • 2000
Highly Influential
4 Excerpts

Pharmacokinetics and pharmacodynamics of antidiabetic drugs-from the viewpoints of drug transporters and metabolic enzymes

  • I. Leiri
  • Nihon Rinsho
  • 2015
1 Excerpt

Similar Papers

Loading similar papers…